Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipients.
Schmidt
G M
GM
Department of Hematology, City of Hope National Medical Center, Duarte, California 91010.
Kovacs
A
A
Zaia
J A
JA
Horak
D A
DA
Blume
K G
KG
Nademanee
A P
AP
O'Donnell
M R
MR
Snyder
D S
DS
Forman
S J
SJ
D000212:Acyclovir / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D003587:Cytomegalovirus / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D005260:Female; D015774:Ganciclovir; D006801:Humans; D007116:Immunization, Passive; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000188:drug therapy / Q000628:therapy*; D011658:Pulmonary Fibrosis / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*
D000914:Antibodies, Viral; D015774:Ganciclovir; D000212:Acyclovir